Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Matrix Capital Management

Founders David Goel Paul Ferri

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 39
Average round size
info
The average size of a deal this fund participated in
$122M
Portfolio companies 26
Rounds per year 1.56
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 3
Key employees 7

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Artificial Intelligence
Summary

Matrix Capital Management is the famous VC, which was founded in 1999. The main office of represented VC is situated in the Waltham. The company was established in North America in United States.

This organization was formed by David Goel, Paul Ferri. Besides them, we counted 7 critical employees of this fund in our database.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Matrix Capital Management, startups are often financed by Valar Ventures, Viking Global Investors, Illumina Accelerator. The meaningful sponsors for the fund in investment in the same round are Matrix Partners, Valar Ventures, Worldview Technology Partners. In the next rounds fund is usually obtained by Valar Ventures, TechAccel LLC, TCV.

Among the most popular fund investment industries, there are SaaS, Artificial Intelligence. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Adaptive Biotechnologies, Encoded Therapeutics, Inc., EpiBiome. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

Opposing the other organizations, this Matrix Capital Management works on 18 percentage points less the average amount of lead investments. Deals in the range of 50 - 100 millions dollars are the general things for fund. When the investment is from Matrix Capital Management the average startup value is 500 millions - 1 billion dollars. The high activity for fund was in 2016. The top amount of exits for fund were in 2019. Considering the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Matrix Capital Management:
Typical Co-investors
Matrix Capital Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Matrix Capital Management:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
A. Soriano Corporation Makati, Manila, Philippines
Bank of Kochi Japan, Kochi, Kochi Prefecture
Beijing Ruibang Kaiyuan Investment Beijing, Beijing, China
Beijing Yansai Luyou Touzi Co., Ltd. Beijing, China, Huairou
Business Instincts Group Alberta, Calgary, Canada
CEED - Centre for Entrepreneurship Education and Development Canada, Halifax, Nova Scotia
Elegant Themes California, San Francisco, United States
Enron North America -
Huamei International China, Guangdong, Guangzhou
Hyppo Corporation -
JP Asia Prime Capital Central, Central Region, Singapore
MG Holdings China, Guangdong, Shenzhen
Mitsubishi Electric Affiliate -
Ritchie Capital Management Cayman Islands, Grand Cayman
Samsung Electronics Seoul, Seoul-t'ukpyolsi, South Korea
Tamar Ventures Herzliya, Israel, Tel Aviv
TEV | Tengelmann Ventures Essen, Germany, Nordrhein-Westfalen
Var Business Angels France, Provence-Alpes-Cote d'Azur, Toulon
Visa Ventures California, San Francisco, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Esker Therapeutics

Biotechnology
Life Science
$259M06 Mar 2024 -

ReCode Therapeutics

Biopharma
Biotechnology
Health Care
Pharmaceutical
Wellness
$50M19 Sep 2023 Dallas, Texas, United States

AltPep

Biotechnology
$52M22 Jun 2023 Washington, United States

ACELYRIN

Biopharma
Biotechnology
Health Care
$300M13 Sep 2022 Los Angeles, California, United States

Monod Bio

Biotechnology
Health Care
Medical
$25M15 Aug 2022 Seattle, Washington, United States

ReCode Therapeutics

Biopharma
Biotechnology
Health Care
Pharmaceutical
Wellness
$120M29 Jun 2022 Dallas, Texas, United States

Talos Trading

Cryptocurrency
FinTech
$105M10 May 2022 New York, New York, United States

Koneksa Health

Analytics
Big Data
Health Care
$45M07 Feb 2022 New York, New York, United States

Blockdaemon

Bitcoin
Blockchain
Cloud Infrastructure
Cloud Management
Computer
Cryptocurrency
Ethereum
FinTech
$207M26 Jan 2022 Los Angeles, California, United States
News
Blockdaemon Raises $155 Million In Series B Funding Making it the World’s Largest Blockchain Node Infrastructure Company

– Blockdaemon closed a Series B funding round of USD $155m with a valuation of $1.255b, making it the world’s largest blockchain infrastructure company for node management and staking.
– The round was led by SoftBank Vision Fund 2, with participation from Matrix Capital Management, Sapphire Ventures, and Morgan Creek Digital.
– This follows the company’s Series A Round in June 2021 of $28m, as well as previous strategic investments, bringing the total to just under $190m.
– Over the last 90 days, Blockdaemon has significantly accelerated its growth and increased its managed node count from 8,000 to 18,000, more than doubling its operational footprint.

GentiBio Raises $157M in Series A Financing

– GentiBio, Inc. from Boston develops engineered regulatory T cells (Tregs) therapies for immunology.
– Series A $157m round was led by Matrix Capital Management with participation from Avidity Partners, JDRF T1D Fund, OrbiMed, RA Capital Management, and Novartis Venture Fund.
– The company intends to use the funds to advance its potential functional cure for Type 1 Diabetes (T1D) to the clinic alongside multiple other pipeline programs in chronic autoimmunity and autoinflammation.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Matrix Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 39
Average round size 122M
Rounds per year 1.56
Peak activity year 2021
Lead investments 6
Follow on index 0.33
Exits 3
Group Appearance index 0.95

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Esker Therapeutics

Biotechnology
Life Science
$259M06 Mar 2024 -

ReCode Therapeutics

Biopharma
Biotechnology
Health Care
Pharmaceutical
Wellness
$50M19 Sep 2023 Dallas, Texas, United States

AltPep

Biotechnology
$52M22 Jun 2023 Washington, United States

ACELYRIN

Biopharma
Biotechnology
Health Care
$300M13 Sep 2022 Los Angeles, California, United States

Monod Bio

Biotechnology
Health Care
Medical
$25M15 Aug 2022 Seattle, Washington, United States

ReCode Therapeutics

Biopharma
Biotechnology
Health Care
Pharmaceutical
Wellness
$120M29 Jun 2022 Dallas, Texas, United States

Talos Trading

Cryptocurrency
FinTech
$105M10 May 2022 New York, New York, United States

Koneksa Health

Analytics
Big Data
Health Care
$45M07 Feb 2022 New York, New York, United States

Blockdaemon

Bitcoin
Blockchain
Cloud Infrastructure
Cloud Management
Computer
Cryptocurrency
Ethereum
FinTech
$207M26 Jan 2022 Los Angeles, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: